Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06542549
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-28
Brief Title:
Efficacy and Safety of AK104 PD-1CTLA-4 Bispecial Antibody Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer
Sponsor:
Organization:
None